[[1] Agler HL, Evans J, Tay LH, Anderson MJ, Colecraft HM, Yue DT. G protein-gated inhibitory module of N-type (Cav2.2) Ca2+ channels. Neuron. 2005; 46:891-904.10.1016/j.neuron.2005.05.01115953418]Search in Google Scholar
[[2] Aguado C, Garcia-Madrona S, Gil-Minguez M, Lujan R. Ontogenic Changes and Differential Localization of T-type Ca(2+) Channel Subunits Cav3.1 and Cav3.2 in Mouse Hippocampus and Cerebellum. Front Neuroanat. 2016; 10:83.]Search in Google Scholar
[[3] Ayoola C, Hwang SM, Hong SJ, Rose KE, Boyd C, Bozic N, Park JY, Osuru HP, DiGruccio MR, Covey DF, Jevtovic-Todorovic V, Todorovic SM. Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. Psychopharmacology (Berl). 2014; 231:3503-15.10.1007/s00213-014-3588-0413504424800894]Search in Google Scholar
[[4] Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, Chemin J. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci. 2009; 29:13106-14.10.1523/JNEUROSCI.2919-09.2009666521119846698]Search in Google Scholar
[[5] Berthier C, Monteil A, Lory P, Strube C. Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice. J Physiol. 2002; 539:681-91.10.1113/jphysiol.2001.013246229018111897840]Search in Google Scholar
[[6] Blesneac I, Chemin J, Bidaud I, Huc-Brandt S, Vandermoere F, Lory P. Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties. Proc Natl Acad Sci U S A. 2015; 112:13705-10.10.1073/pnas.1511740112464075926483470]Search in Google Scholar
[[7] Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A, Nargeot J. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J. 2005; 24:315-24.10.1038/sj.emboj.760051554580715616581]Search in Google Scholar
[[8] Boycott HE, Dallas ML, Elies J, Pettinger L, Boyle JP, Scragg JL, Gamper N, Peers C. Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin. FASEB J. 2013; 27:3395-407.10.1096/fj.13-22724923671274]Search in Google Scholar
[[9] Braun M, Ramracheya R, Bengtsson M, Zhang Q, Karanauskaite J, Partridge C, Johnson PR, Rorsman P. Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes. 2008; 57:1618-28.10.2337/db07-099118390794]Search in Google Scholar
[[10] Cohen DM. Regulation of TRP channels by N-linked glycosylation. Semin Cell Dev Biol. 2006; 17:630-7. 10.1016/j.semcdb.2006.11.00717215147]Search in Google Scholar
[[11] Cribbs LL, Lee JH, Yang J, Satin J, Zhang Y, Daud A, Barclay J, Williamson MP, Fox M, Rees M, Perez-Reyes E. Cloning and characterization of a1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res. 1998; 83:103-9.10.1161/01.RES.83.1.1039670923]Search in Google Scholar
[[12] Darszon A, Lopez-Martinez P, Acevedo JJ, Hernandez-Cruz A, Trevino CL. T-type Ca2+ channels in sperm function. Cell Calcium. 2006; 40:241-52.10.1016/j.ceca.2006.04.02816797697]Search in Google Scholar
[[13] Eckle VS, Shcheglovitov A, Vitko I, Dey D, Yap CC, Winckler B, Perez-Reyes E. Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility. J Physiol. 2014; 592:795-809.10.1113/jphysiol.2013.264176393471524277868]Search in Google Scholar
[[14] Elies J, Scragg JL, Boyle JP, Gamper N, Peers C. Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: emerging controversies concerning the role of H2 S in nociception. J Physiol. 2016; 594:4119-29.10.1113/JP270963496774126804000]Search in Google Scholar
[[15] Elies J, Scragg JL, Dallas ML, Huang D, Huang S, Boyle JP, Gamper N, Peers C. Inhibition of T-type Ca2+ Channels by Hydrogen Sulfide. Adv Exp Med Biol. 2015; 860:353-60.10.1007/978-3-319-18440-1_4026303500]Search in Google Scholar
[[16] Elies J, Scragg JL, Huang S, Dallas ML, Huang D, MacDougall D, Boyle JP, Gamper N, Peers C. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels. FASEB J. 2014; 28:5376-87. 10.1096/fj.14-25711325183670]Search in Google Scholar
[[17] Ernst WL, Zhang Y, Yoo JW, Ernst SJ, Noebels JL. Genetic enhancement of thalamocortical network activity by elevating alpha 1g-mediated low-voltage-activated calcium current induces pure absence epilepsy. J Neurosci. 2009; 29:1615-25.10.1523/JNEUROSCI.2081-08.2009266067319211869]Search in Google Scholar
[[18] Ferdous Z, Qureshi MA, Jayaprakash P, Parekh K, John A, Oz M, Raza H, Dobrzynski H, Adrian TE, Howarth FC. Different Profile of mRNA Expression in Sinoatrial Node from Streptozotocin- Induced Diabetic Rat. PLoS One. 2016; 11:e0153934.10.1371/journal.pone.0153934483825827096430]Search in Google Scholar
[[19] Gadotti VM, Caballero AG, Berger ND, Gladding CM, Chen L, Pfeifer TA, Zamponi GW. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain. Mol Pain. 2015; 11:12.10.1186/s12990-015-0011-8436409925889575]Search in Google Scholar
[[20] Garcia-Caballero A, Gadotti VM, Chen L, Zamponi GW. A cellpermeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain. Mol Pain. 2016; 12.10.1177/1744806916642444495596627130589]Search in Google Scholar
[[21] Garcia-Caballero A, Gadotti VM, Stemkowski P, Weiss N, Souza IA, Hodgkinson V, Bladen C, Chen L, Hamid J, Pizzoccaro A, Deage M, Francois A, Bourinet E, Zamponi GW. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron. 2014; 83:1144-58.]Search in Google Scholar
[[22] Gilmore AJ, Heblinski M, Reynolds A, Kassiou M, Connor M. Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT. Br J Pharmacol. 2012; 167:1076-88.10.1111/j.1476-5381.2012.02047.x349298822624680]Search in Google Scholar
[[23] Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.Ca2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007; 100:342-53.10.1161/01.RES.0000256155.31133.49]Search in Google Scholar
[[24] Heron SE, Khosravani H, Varela D, Bladen C, Williams TC, Newman MR, Scheffer IE, Berkovic SF, Mulley JC, Zamponi GW. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol. 2007; 62:560-8.10.1002/ana.21169]Search in Google Scholar
[[25] Heron SE, Phillips HA, Mulley JC, Mazarib A, Neufeld MY, Berkovic SF, Scheffer IE. Genetic variation of CACNA1H in idiopathic generalized epilepsy. Ann Neurol. 2004; 55:595-6.10.1002/ana.20028]Search in Google Scholar
[[26] Hu C, Depuy SD, Yao J, McIntire WE, Barrett PQ. Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers. J Biol Chem. 2009; 284:7465-73.10.1074/jbc.M808049200]Search in Google Scholar
[[27] Huang D, Huang S, Gao H, Liu Y, Qi J, Chen P, Wang C, Scragg JL, Vakurov A, Peers C, Du X, Zhang H, Gamper N. Redox-Dependent Modulation of T-Type Ca(2+) Channels in Sensory Neurons Contributes to Acute Anti-Nociceptive Effect of Substance P. Antioxid Redox Signal. 2016; 25:233-51.10.1089/ars.2015.6560]Search in Google Scholar
[[28] Huguenard JR. Low-voltage-activated (T-type) calcium-channel genes identified. Trends Neurosci. 1998; 21:451-2.10.1016/S0166-2236(98)01331-9]Search in Google Scholar
[[29] Husse B, Franz WM. Generation of cardiac pacemaker cells by programming and differentiation. Biochim Biophys Acta. 2016; 1863:1948-52.10.1016/j.bbamcr.2015.12.00426681531]Search in Google Scholar
[[30] Chemin J, Mezghrani A, Bidaud I, Dupasquier S, Marger F, Barrere C, Nargeot J, Lory P. Temperature-dependent modulation of CaV3 T-type calcium channels by protein kinases C and A in mammalian cells. J Biol Chem. 2007; 282:32710-8.10.1074/jbc.M70274620017855364]Search in Google Scholar
[[31] Chemin J, Monteil A, Perez-Reyes E, Bourinet E, Nargeot J, Lory P. Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability. J Physiol. 2002; 540:3-14.10.1113/jphysiol.2001.013269229020911927664]Search in Google Scholar
[[32] Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J. 2001; 20:7033-40.10.1093/emboj/20.24.703312577911742980]Search in Google Scholar
[[33] Chen Y, Lu J, Pan H, Zhang Y, Wu H, Xu K, Liu X, Jiang Y, Bao X, Yao Z, Ding K, Lo WH, Qiang B, Chan P, Shen Y, Wu X. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol. 2003; 54:239-43.10.1002/ana.10607]Search in Google Scholar
[[34] Kang HW, Park JY, Jeong SW, Kim JA, Moon HJ, Perez-Reyes E, Lee JH. A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels. J Biol Chem. 2006; 281:4823-30.10.1074/jbc.M510197200]Search in Google Scholar
[[35] Kawabata A, Ishiki T, Nagasawa K, Yoshida S, Maeda Y, Takahashi T, Sekiguchi F, Wada T, Ichida S, Nishikawa H. Hydrogen sulfide as a novel nociceptive messenger. Pain. 2007; 132:74-81.10.1016/j.pain.2007.01.026]Search in Google Scholar
[[36] Kim D, Song I, Keum S, Lee T, Jeong MJ, Kim SS, McEnery MW, Shin HS. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking a1G T-type Ca2+ channels. Neuron. 2001; 31:35-45.10.1016/S0896-6273(01)00343-9]Search in Google Scholar
[[37] Lacinova L. Pharmacology of recombinant low-voltage activated calcium channels. Curr Drug Targets CNS Neurol Disord. 2004; 3:105-11.10.2174/156800704348254315078185]Search in Google Scholar
[[38] Lacinova L. Voltage-dependent calcium channels. Gen Physiol Biophys. 2005; 24 Suppl 1:1-78. ]Search in Google Scholar
[[39] Lacinova L, Klugbauer N, Hofmann F. Low voltage activated calcium channels: from genes to function. Gen Physiol Biophys. 2000; 19:121-36.]Search in Google Scholar
[[40] Lalevee N, Rebsamen MC, Barrere-Lemaire S, Perrier E, Nargeot J, Benitah JP, Rossier MF. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res. 2005; 67:216-24.10.1016/j.cardiores.2005.05.00915919070]Search in Google Scholar
[[41] Lazniewska J, Rzhepetskyy Y, Zhang FX, Zamponi GW, Weiss N. Cooperative roles of glucose and asparagine-linked glycosylation in T-type calcium channel expression. Pflugers Arch. 2016.10.1007/s00424-016-1881-y27659162]Search in Google Scholar
[[42] Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol. 2011; 51:169-87.10.1146/annurev-pharmtox-010510-10050521210746]Search in Google Scholar
[[43] M’Dahoma S, Gadotti VM, Zhang FX, Park B, Nam JH, Onnis V, Balboni G, Lee JY, Zamponi GW. Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain. Pflugers Arch. 2016; 468:193-9.10.1007/s00424-015-1733-126354962]Search in Google Scholar
[[44] Maturana A, Lenglet S, Python M, Kuroda S, Rossier MF. Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes. Endocrinology. 2009; 150:3726-34.10.1210/en.2008-172719443576]Search in Google Scholar
[[45] Monteil A, Chemin J, Leuranguer V, Altier C, Mennessier G, Bourinet E, Lory P, Nargeot J. Specific properties of T-type calcium channels generated by the human a1I subunit. J Biol Chem. 2000; 275:16530-5.10.1074/jbc.C00009020010749850]Search in Google Scholar
[[46] Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol. 2012; 13:448-62.10.1038/nrm3383393401122722607]Search in Google Scholar
[[47] Nelson MT, Woo J, Kang HW, Vitko I, Barrett PQ, Perez-Reyes E, Lee JH, Shin HS, Todorovic SM. Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. Journal of Neuroscience. 2007; 27:8250-8260.10.1523/JNEUROSCI.1800-07.2007667306817670971]Search in Google Scholar
[[48] Ohkubo T, Inoue Y, Kawarabayashi T, Kitamura K. Identification and electrophysiological characteristics of isoforms of T-type calcium channel Ca(v)3.2 expressed in pregnant human uterus. Cell Physiol Biochem. 2005; 16:245-54.10.1159/00008985016301824]Search in Google Scholar
[[49] Ondacova K, Karmazinova M, Lazniewska J, Weiss N, Lacinova L. Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation. Channels (Austin). 2016; 10:175-84.10.1080/19336950.2016.1138189495458426745591]Search in Google Scholar
[[50] Orestes P, Osuru HP, McIntire WE, Jacus MO, Salajegheh R, Jagodic MM, Choe W, Lee J, Lee SS, Rose KE, Poiro N, Digruccio MR, Krishnan K, Covey DF, Lee JH, Barrett PQ, Jevtovic-Todorovic V, Todorovic SM. Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels. Diabetes. 2013; 62:3828-38.10.2337/db13-0813380661223835327]Search in Google Scholar
[[51] Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev. 2003; 83:117-61.10.1152/physrev.00018.200212506128]Search in Google Scholar
[[52] Ross HR, Gilmore AJ, Connor M. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. Br J Pharmacol. 2009; 156:740-50.10.1111/j.1476-5381.2008.00072.x269774719226289]Search in Google Scholar
[[53] Rzhepetskyy Y, Lazniewska J, Blesneac I, Pamphlett R, Weiss N. CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing. Channels (Austin). 2016; 10:466-77.10.1080/19336950.2016.1204497503477627331657]Search in Google Scholar
[[54] Scholl UI, Stolting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife. 2015; 4:e06315.10.7554/eLife.06315440844725907736]Search in Google Scholar
[[55] Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A. 2005; 102:8089-96; discussion 8086-8.10.1073/pnas.0502506102114942815863612]Search in Google Scholar
[[56] Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager- Flusberg H, Priori SG, Sanguinetti MC, Keating MT. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004; 119:19-31.10.1016/j.cell.2004.09.01115454078]Search in Google Scholar
[[57] Splawski I, Yoo DS, Stotz SC, Cherry A, Clapham DE, Keating MT. CACNA1H mutations in autism spectrum disorders. J Biol Chem. 2006; 281:22085-91.10.1074/jbc.M60331620016754686]Search in Google Scholar
[[58] Steinberg KM, Yu B, Koboldt DC, Mardis ER, Pamphlett R. Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS. Sci Rep. 2015; 5:9124.10.1038/srep09124436064125773295]Search in Google Scholar
[[59] Todorovic SM, Jevtovic-Todorovic V. Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling. Pflugers Arch. 2013; 465:921-7.10.1007/s00424-012-1211-y23322114]Search in Google Scholar
[[60] Ufret-Vincenty CA, Baro DJ, Lederer WJ, Rockman HA, Quinones LE, Santana LF. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J Biol Chem. 2001; 276:28197-203. 10.1074/jbc.M10254820011369778]Search in Google Scholar
[[61] Wang G, Bochorishvili G, Chen Y, Salvati KA, Zhang P, Dubel SJ, Perez-Reyes E, Snutch TP, Stornetta RL, Deisseroth K, Erisir A, Todorovic SM, Luo JH, Kapur J, Beenhakker MP, Zhu JJ. CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy. Genes Dev. 2015; 29:1535-51.10.1101/gad.260869.115452673726220996]Search in Google Scholar
[[62] Watanabe I, Wang HG, Sutachan JJ, Zhu J, Recio-Pinto E, Thornhill WB. Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism. J Physiol. 2003; 550:51-66.10.1113/jphysiol.2003.040337234301312879861]Search in Google Scholar
[[63] Weiss N, Black SA, Bladen C, Chen L, Zamponi GW. Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation. Pflugers Arch. 2013; 465:1159-70.10.1007/s00424-013-1259-323503728]Search in Google Scholar
[[64] Welsby PJ, Wang H, Wolfe JT, Colbran RJ, Johnson ML, Barrett PQ. A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II. J Neurosci. 2003; 23:10116-21.10.1523/JNEUROSCI.23-31-10116.2003]Search in Google Scholar
[[65] Yao J, Davies LA, Howard JD, Adney SK, Welsby PJ, Howell N, Carey RM, Colbran RJ, Barrett PQ. Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulindependent protein kinase II. J Clin Invest. 2006; 116:2403-12.]Search in Google Scholar
[[66] Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev. 2015; 67:821-70.10.1124/pr.114.009654463056426362469]Search in Google Scholar
[[67] Zhang Y, Cribbs LL, Satin J. Arachidonic acid modulation of alpha1H, a cloned human T-type calcium channel. Am J Physiol Heart Circ Physiol. 2000; 278:H184-93.10.1152/ajpheart.2000.278.1.H18410644598]Search in Google Scholar
[[68] Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003; 302:826-30.10.1126/science.108907114593168]Search in Google Scholar